DMU-212

CAS No. 134029-62-2

DMU-212( —— )

Catalog No. M28078 CAS No. 134029-62-2

DMU-212, a methylated form of Resveratrol, shows antimitotic, antiproliferative, and antioxidant activities. DMU-212 induces mitotic arrest through the activation of ERK1/2 protein and the promotion of apoptosis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 27 Get Quote
5MG 43 Get Quote
10MG 72 Get Quote
25MG 147 Get Quote
50MG 259 Get Quote
100MG 385 Get Quote
500MG 872 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    DMU-212
  • Note
    Research use only, not for human use.
  • Brief Description
    DMU-212, a methylated form of Resveratrol, shows antimitotic, antiproliferative, and antioxidant activities. DMU-212 induces mitotic arrest through the activation of ERK1/2 protein and the promotion of apoptosis.
  • Description
    DMU-212, a methylated form of Resveratrol, shows antimitotic, antiproliferative, and antioxidant activities. DMU-212 induces mitotic arrest through the activation of ERK1/2 protein and the promotion of apoptosis.(In Vitro):DMU-212 (0.3125-40 μM) inhibited the cellular proliferation of human melanoma cells at submicromolar or micromolar concentrations (IC50=0.5 μM, 0.5 μM, 1.25 μM, and 1.25 μM for A375, Bro, MeWo, and M5 human melanoma cells, respectively.).(In Vivo):In SCID female mice, DMU-212 (50 mg/kg; i.g.) inhibited tumor growth and lowered tumor burden.
  • In Vitro
    Cell Proliferation Assay Cell Line:A375 cells, MeWo cells, M5 cells, Bro cells Concentration:0.3125 μM, 0,625 μM, 1.25 μM, 2.5 μM, 5 μM, 10 μM, 20 μM, 40 μM Incubation Time:96 hours Result:Inhibited the cellular proliferation of human melanoma cells at submicromolar or micromolar concentrations (IC50=0.5 μM for A375 and Bro and IC50= 1.25 μM for MeWo and M5 cells).Cell Cycle Analysis Cell Line:A375 cells Concentration:20 μM, 30 μM, 50 μM Incubation Time:24 hoursResult:Caused a marked increase in the levels of p21, p53 and cyclin B1 proteins with a concomitant decrease in the levels of cyclin A2.Western Blot Analysis Cell Line:A375 cells Concentration:20 μM, 30 μM, 50 μM Incubation Time:24 hours Result:Significant upregulated Bax, caspase 3 and caspase 9 protein levels, while decreased the levels of the anti-apoptotic protein Bcl-2.Apoptosis Analysis Cell Line:A375 cells Concentration:10 μM, 20 μM Incubation Time:24 hours, 36 hoursResult:Induced apoptosis.
  • In Vivo
    Animal Model:6-weeks-old SCID female mice (20-24 g), with ovarian cancer xenografts Dosage:50 mg/kg Administration:Oral gavage, three times a week, for 14 days Result:Lowered tumor burden.
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    Apoptosis
  • Recptor
    Tubulin polymerization
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    134029-62-2
  • Formula Weight
    300.35
  • Molecular Formula
    C18H20O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 20 mg/mL (66.59 mM)
  • SMILES
    COC1=CC=C(/C=C/C2=CC(OC)=C(OC)C(OC)=C2)C=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Schneider Y, et al. Resveratrol analog (Z)-3,5,4'-trimethoxystilbene is a potent anti-mitotic drug inhibiting tubulin polymerization. Int J Cancer. 2003 Nov 1;107(2):189-96.
molnova catalog
related products
  • 3-O-Methylgallic aci...

    3,4-Dihydroxy-5-methoxybenzoic acid reduces cell proliferation in Caco-2 cells(IC50 = 24.1 μM) more effectively than anthocyanins and may offer protection against colon cancer after its formation in the gut. 3,4-Dihydroxy-5-methoxybenzoic acid inhibits transcription factors NF-κB, AP-1, STAT-1, and OCT-1 which are known to be activated in colorectal cancer.

  • Atrosab

    Atrosab is a humanized IgG1 antibody targeting TNFR1, inhibiting TNF-mediated apoptosis, and can be used to study inflammatory and neurodegenerative diseases.

  • p53 Activator 7

    p53 Activator 7 is a highly potent and cell-permeable activator of the p53 mutation Y220C (MDM-2/p53), which induces apoptosis.